Spire Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $244K | Sell |
|
|||||
|
2025
Q2 | $671K | Sell |
|
|||||
|
2025
Q1 | $893K | Buy |
|
|||||
|
2024
Q4 | $1.02M | Sell |
|
|||||
|
2024
Q3 | $2.27M | Buy |
|
|||||
|
2024
Q2 | $2.32M | Buy |
|
|||||
|
2024
Q1 | $1.85M | Buy |
|
|||||
|
2023
Q4 | $996K | Buy |
|
|||||
|
2023
Q3 | $555K | Buy |
|
|||||
|
2023
Q2 | $493K | Sell |
|
|||||
|
2023
Q1 | $523K | Buy |
|
|||||
|
2022
Q4 | $252K | Buy |
|
|||||
|
2022
Q3 | $170K | Sell |
|
|||||
|
2022
Q2 | $400K | Sell |
|
|||||
|
2022
Q1 | $630K | Sell |
|
|||||
|
2021
Q4 | $827K | Buy |
|
|||||
|
2021
Q3 | $670K | Sell |
|
|||||
|
2021
Q2 | $658K | Sell |
|
|||||
|
2021
Q1 | $1M | Buy |
|